Abstract:Background and Aim:No cohort studies have been performed on Chinese primary retroperitoneal sarcoma (RPS) patients. Data derived from western cohort studies may not be directly superimposable on Asian counterparts. Furthermore, the risk factors for survival of RPS are currently unknown for Chinese patients. The objectives were therefore to (1) gain insight into RPS incidence and patient demographics and clinical details; (2) determine the risk factors for overall survival (OS) and disease-free survival (DFS); and (3) critically appraise the Asian cohort data in relation to information obtained in western cohort studies.Methods:In this retrospective cohort study, the health records of patients that had been diagnosed with primary localized RPS with curative intent between 2009 and 2020 were analyzed. Cox proportional hazards analysis was conducted to evaluate the risk factors for OS and DFS.Results:A total of 261 patients met the inclusion criteria. Ninety-six (36.8%) patients had been diagnosed with well-differentiated liposarcoma, 63 patients (24.1%) with dedifferentiated liposarcoma, 41 patients (15.7%) with leiomyosarcoma (LMS), 22 patients (8.4%) with solitary fibroma, 7 patients (2.7%) with malignant peripheral nerve sheath tumor (MPNST), and 32 patients (12.3%) with another type of RPS. The study further revealed that (1) the 5-y OS and DFS in RPS patients was 67.8% and 51.3%, respectively, with the highest OS and DFS observed in MPNST (100% and 100%, respectively) and the lowest 5-y OS and DFS attributed to LMS (42.6% and 28.9%, respectively); (2) symptoms at presentation, Federal National Cancer Center (FNCLCC) grade, and number of combined resections are independent risk factors in OS; (3) symptoms at presentation, FNCLCC grade, chemotherapy, and hospital length of stay are independent risk factors for DFS; and (4) patients at high risk (symptoms at presentation and high-grade tumors) have less than half the chance of survival at 5 y post-diagnosis than patients with a low-risk profile.Conclusions:Symptoms at presentation constitute a risk factor for OS and DFS. When combined with tumor grade - another risk factor for both OS and DFS - patients can be classified into a high-risk and low-risk category to gauge a patient's prognosis and, accordingly, frame an optimal clinical trajectory. Moreover, the clinicopathology and overall prognosis of RPS in Asian and Western populations are comparable and hence superimposable.Relevance for Patients:The present study identifies the risk factors of survival in RPS and suggests symptoms at presentation should be considered in the preoperative consultation and added in prognostic grouping.

Molecular Markers of Proliferation, DNA Repair, and Immune Infiltration Defines High-Risk Subset of Resectable Retroperitoneal Sarcomas

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

Molecular Feature-Based Classification of Retroperitoneal Liposarcoma: A Prospective Cohort Study

Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma

Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated Sarcomas

Retroperitoneal soft tissue sarcomas: Predictive factors for incomplete resection

Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review

Retroperitoneal Dedifferentiated Liposarcoma: Analysis of 61 Cases from a Large Institution.

Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches

Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

The Impact of Perioperative Radiotherapy on Disease-Specific Survival in Patients with Localized Retroperitoneal Liposarcoma: A Population-Based Propensity-Score Matched Analysis

Prognostic Significance of Pretreatment Lymphocyte/monocyte Ratio in Retroperitoneal Liposarcoma Patients after Radical Resection

Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.

Comprehensive Immune Characterization and T-cell Receptor Repertoire Heterogeneity of Retroperitoneal Liposarcoma

Impact of Time to First Relapse on Long-Term Outcome in Adult Retroperitoneal Sarcoma Patients after Radical Resection

Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma

Prognostic Factors in Patients with Recurrent or Metastatic Retroperitoneal Leiomyosarcoma.

Radical Versus Non-Radical Resection for Early-Stage Retroperitoneal Sarcoma: A Propensity Score-Matched Analysis

Tumor Grade and Symptoms at Presentation Are Survival Risk Factors in Chinese Patients with Primary Retroperitoneal Sarcoma.

Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors